Data Insight: Preventive Care Takes Pandemic Hit, Results in Missed Diagnoses
This Data Insight examines 2020 claims data for pap smears, colonoscopies, and mammograms to estimate the toll that missed preventive screenings will have on patients. Findings from the analysis show that thousands of privately insured Americans have missed cancer diagnoses during the pandemic, and their first-year healthcare costs amount to nearly 750 million dollars. To address the lapse in care, high-risk groups who missed screenings should return for in-person preventive care as soon as possible.
Published on October 08, 2021
